Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G O'Brien

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Carcinogenesis|August 7, 2007
Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesisXiaojing Wang, David J Feith, Pat Welsh, et al.
The Journal of Urology|January 10, 2004
Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer riskKala Visvanathan, Kathy J Helzlsouer, David W Boorman, et al.
Journal of Veterinary Dentistry|December 31, 2013
Polyamine inhibitors for treatment of feline oral squamous cell carcinoma: a proof-of-concept studyJohn R Lewis, Thomas G O'Brien, Katherine A Skorupski, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2003
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase geneMaria Elena Martinez, Thomas G O'Brien, Kimberly E Fultz, et al.
Journal of the National Cancer Institute|October 19, 2006
Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma preventionElizabeth L R Barry, John A Baron, Shubha Bhat, et al.
Toxicology|October 12, 2007
Folate deficiency enhances arsenic effects on expression of genes involved in epidermal differentiation in transgenic K6/ODC mouse skinGail M Nelson, Gene J Ahlborn, Don A Delker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Androgen receptor CAG repeat length and risk of biliary tract cancer and stonesTamra E Meyer, Thomas G O'Brien, Gabriella Andreotti, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Carcinogenesis|August 7, 2007
Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesisXiaojing Wang, David J Feith, Pat Welsh, et al.
The Journal of Urology|January 10, 2004
Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer riskKala Visvanathan, Kathy J Helzlsouer, David W Boorman, et al.
Journal of Veterinary Dentistry|December 31, 2013
Polyamine inhibitors for treatment of feline oral squamous cell carcinoma: a proof-of-concept studyJohn R Lewis, Thomas G O'Brien, Katherine A Skorupski, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2003
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase geneMaria Elena Martinez, Thomas G O'Brien, Kimberly E Fultz, et al.
Journal of the National Cancer Institute|October 19, 2006
Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma preventionElizabeth L R Barry, John A Baron, Shubha Bhat, et al.
Toxicology|October 12, 2007
Folate deficiency enhances arsenic effects on expression of genes involved in epidermal differentiation in transgenic K6/ODC mouse skinGail M Nelson, Gene J Ahlborn, Don A Delker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Androgen receptor CAG repeat length and risk of biliary tract cancer and stonesTamra E Meyer, Thomas G O'Brien, Gabriella Andreotti, et al.
Pageof 2